Sharekhan recommended Hold rating on Jyothy Laboratories with a target price of Rs 180 in its research report dated June 24, 2019.
Sharekhan's research report on Jyothy Laboratories
Management expects 12-14% revenue growth with OPM at 16% due to expected recovery in H2FY2020. We have factored in 10% revenue growth and ~15% OPM for FY2020 on account of slow recovery in the HI category and higher media spends. Any substantial recovery in business fundamentals (likely to be in H2FY2020) will be a key re-rating trigger for the stock.
We maintain our Hold recommendation on Jyothy Laboratories with a revised PT of Rs. 180. HI category will recover but at a gradual space; fabric whitener will grow in mid-single digit; other categories to grow in double digits.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.